Dive into the latest trending topics in global health with IHME’s Global Health Insights podcast. Our health researchers explain the significance of new studies, share data related to current events, and help you understand the story behind the numbers.

IHME’s Global Health Insights
Claim This Podcastby Institute for Health Metrics and Evaluation
Podcast Authority
Beta
Podcast Overview
Dive into the latest trending topics in global health with IHME’s Global Health Insights podcast. Our health researchers explain the significance of new studies, share data related to current events, and help you understand the story behind the numbers.
Language
🇺🇲
Publishing Since
1/18/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind IHME’s Global Health Insights
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

March 11, 2026
Delivering scientific evidence through the NUS-IHME Global Burden of Disease Research Centre
The NUS-IHME Global Burden of Disease Research Centre is a new regional hub to serve as a key analytical engine for Southeast Asia and the surrounding region by delivering scientific evidence that its leaders can translate into policy. We discuss the Centre with IHME Director Dr. Christopher Murray and Professor Chong Yap Seng, Dean of NUS Medicine, the Yong Loo Lin School of Medicine at the National University of Singapore.__________________________________ An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. In making our research available and approachable, we aim to inform health policy and practice in pursuit of our vision: all people living long lives in full health. Learn more about IHME. Where to follow us: LinkedInFacebookX (Twitter)YouTube

February 25, 2026
How health systems and social determinants of health can guide policy
IHME Director Dr. Christopher Murray and UCLA Chancellor Dr. Julio Frenk discuss The Lancet Commission on Health Systems Performance Assessment and how the information will allow policymakers and other decision-makers to use resources strategically and improve health outcomes. ___________ An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. In making our research available and approachable, we aim to inform health policy and practice in pursuit of our vision: all people living long lives in full health. Learn more about IHME. Where to follow us: LinkedInFacebookX (Twitter)YouTube

October 14, 2025
Global Burden of Disease 2023 is officially released
The Global Burden of Disease Study (GBD) is the most comprehensive assessment of health trends and conditions across countries. GBD provides detailed analysis of disease burden related to life expectancy, non-communicable diseases, mental health, and many other health topics. We discuss the latest GBD with IHME Director Dr. Christopher Murray. Read the GBD 2023 capstones, published in The Lancet:• Global demographic analysis: http://ms.spr.ly/6047s2bOv• Global causes of death: http://ms.spr.ly/6040s2bOI• Global burden of diseases, injuries, and risk factors: http://ms.spr.ly/6041s2bOLAccess and share all things related to GBD 2023: updated data visualization tools, comprehensive infographics, informative videos, workshops, webinars, and more: https://www.healthdata.org/announcing-launch-gbd-2023-study-results.________________________Transcript Rhonda Stewart: Welcome to Global Health Insights, a podcast from IHME, the Institute for Health Metrics and Evaluation. I’m Rhonda Stewart. In this episode, we’ll hear From IHME director Dr. Christopher Murray as he talks about the latest Global Burden of Disease study, also known as GBD. GBD 2023 is a series of three papers published in The Lancet and presented at the World Health Summit in Berlin. The papers focus on demographic analysis, causes of death, and diseases, injuries, and risk factors. GBD is the largest and most detailed scientific effort undertaken to quantify health trends. GBD provides a unique platform to compare the magnitude of diseases, injuries and risk factors across age groups, sexes, countries, regions, and time. For decision-makers, the GBD approach provides a unique way to compare countries’ health progress and to understand factors that impact health such as high blood pressure, cancer, and heart disease. Led by IHME at the University of Washington, GBD is a truly global effort, with more than 16,000 researchers from over 160 countries and territories participating in the most recent update. The latest GBD includes data on topics ranging from life expectancy to mental health to noncommunicable diseases. Chris, the 2023 Global Burden of Disease study covers three capstones published in The Lancet and presented at the World Health Summit in Berlin. The papers cover demographic analysis, causes of death, and diseases, injuries, and risk factors. Let’s start by talking about the demographic analysis paper. The global age-standardized mortality rate declined significantly since 1950, but that’s only part of the story. What are some of the other key findings from that paper? Christopher Murray: Well, in the demographic analysis, there’s both the long-term view of progress in expanding life expectancy that has been quite steady, except for the big interruptions due to the HIV epidemic in sub-Saharan Africa as well as the sort of mortality crises in Eastern Europe and Central Asia that occurred in the late 80s and 90s. But other than those, up to 2019, we had this sort of pattern of progress that we got used to. Then the COVID epidemic came along: 18 million deaths related to COVID and a big drop in life expectancy, and then it really was even worse in 2021 in many countries. And then it bounced back. And so by 2023, we’ve gone in most places back to 2019 levels, but not back yet to the levels we would have expected if the pandemic hadn’t occurred. So that’s one big part of the story. Another part is the fact that we’ve seen increases in child and adolescent mortality in some parts of the world, particularly some of the high-income countries – the US and Canada stand out. And then we've seen increases in mortality related to drug use disorders, suicides to some extent, in adults that are more in the 25- to 39-year range. And then there are some changes in methods and data that we now think that younger adult mortality in Africa is higher than we previously thought and older adult mortality is little bit lower than we previou
34 total episodes available
Deep-dive analytics for IHME’s Global Health Insights
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is IHME’s Global Health Insights?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.